Literature DB >> 25391240

Effect of cytosine arabinoside metabolizing enzyme expression on drug toxicity in acute myeloid leukemia.

Ajay Abraham1, Anup J Devasia, Savitha Varatharajan, Sreeja Karathedath, Poonkuzhali Balasubramanian, Vikram Mathews.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25391240      PMCID： PMC5681861          DOI： 10.1007/s00277-014-2254-2

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  11 in total

1.  Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia.

Authors:  Ajay Abraham; Savitha Varatharajan; Salar Abbas; Wei Zhang; Ramachandran V Shaji; Rayaz Ahmed; Aby Abraham; Biju George; Alok Srivastava; Mammen Chandy; Vikram Mathews; Poonkuzhali Balasubramanian
Journal:  Pharmacogenomics       Date:  2012-02       Impact factor: 2.533

2.  Cytidine deaminase - the methodological relevance of AraC deamination for ex vivo experiments using cultured cell lines, fresh leukemic blasts, and normal bone marrow cells.

Authors:  J Braess; J Pförtner; W Kern; W Hiddemann; E Schleyer
Journal:  Ann Hematol       Date:  1999-11       Impact factor: 3.673

3.  Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients.

Authors:  F Forghieri; M Luppi; M Morselli; L Potenza
Journal:  Haematologica       Date:  2007-09       Impact factor: 9.941

Review 4.  Optimal induction and post-remission therapy for AML in first remission.

Authors:  Jacob M Rowe
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

Review 5.  The lethality of aranucleotides.

Authors:  S S Cohen
Journal:  Med Biol       Date:  1976-12

6.  Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapies.

Authors:  Joseph Ciccolini; Laetitia Dahan; Nicolas André; Alexandre Evrard; Muriel Duluc; Aurore Blesius; Chenguang Yang; Sarah Giacometti; Caroline Brunet; Caroline Raynal; Adrien Ortiz; Nicolas Frances; Athanassios Iliadis; Florence Duffaud; Jean-François Seitz; Cédric Mercier
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544

Review 7.  Pediatric acute myeloid leukemia: towards high-quality cure of all patients.

Authors:  Gertjan J L Kaspers; Christian M Zwaan
Journal:  Haematologica       Date:  2007-11       Impact factor: 9.941

8.  Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation.

Authors:  Cédric Mercier; Caroline Raynal; Laetitia Dahan; Adrien Ortiz; Alexandre Evrard; Charlotte Dupuis; Aurore Blesius; Muriel Duluc; Fleur Franceschini; Sarah Giacometti; Sébastien Salas; Gérard Milano; Roger Favre; Jean-François Seitz; Joseph Ciccolini
Journal:  Pharmacogenet Genomics       Date:  2007-10       Impact factor: 2.089

9.  Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.

Authors:  Deepika Bhatla; Robert B Gerbing; Todd A Alonzo; Heather Conner; Julie A Ross; Soheil Meshinchi; Xiaowen Zhai; Tiffany Zamzow; Parinda A Mehta; Hartmut Geiger; John Perentesis; Stella M Davies
Journal:  Br J Haematol       Date:  2008-11-22       Impact factor: 6.998

10.  Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.

Authors:  Carlos María Galmarini; Xavier Thomas; Kathryn Graham; Assia El Jafaari; Emeline Cros; Lars Jordheim; John R Mackey; Charles Dumontet
Journal:  Br J Haematol       Date:  2003-07       Impact factor: 6.998
View more
  4 in total

1.  A personalized approach to acute myeloid leukemia therapy: current options.

Authors:  Raveen Stephen Stallon Illangeswaran; Saswati Das; Daniel Zechariah Paul; Vikram Mathews; Poonkuzhali Balasubramanian
Journal:  Pharmgenomics Pers Med       Date:  2019-08-02

2.  The antimicrobial peptide PFR induces necroptosis mediated by ER stress and elevated cytoplasmic calcium and mitochondrial ROS levels: cooperation with Ara-C to act against acute myeloid leukemia.

Authors:  Yudie Lv; Gang Shao; Qiyu Zhang; Xi Wang; Yueming Meng; Lingfei Wang; Feiyan Huang; Tianxin Yang; Yuanting Jin; Caiyun Fu
Journal:  Signal Transduct Target Ther       Date:  2019-10-04

3.  RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia.

Authors:  Ajay Abraham; Savitha Varatharajan; Sreeja Karathedath; Chepsy Philip; Kavitha M Lakshmi; Ashok Kumar Jayavelu; Ezhilpavai Mohanan; Nancy Beryl Janet; Vivi M Srivastava; Ramachandran V Shaji; Wei Zhang; Aby Abraham; Auro Viswabandya; Biju George; Mammen Chandy; Alok Srivastava; Vikram Mathews; Poonkuzhali Balasubramanian
Journal:  Pharmacogenomics       Date:  2015-06-17       Impact factor: 2.533

4.  Evaluation of the impact of single-nucleotide polymorphisms on treatment response, survival and toxicity with cytarabine and anthracyclines in patients with acute myeloid leukaemia: a systematic review protocol.

Authors:  Taynah Cascaes Puty; Jonathan Souza Sarraf; Tabata Cristina Do Carmo Almeida; Valter Cordeiro Barbosa Filho; Luis Eduardo Werneck de Carvalho; Fernando Luiz Affonso Fonseca; Fernando Adami
Journal:  Syst Rev       Date:  2019-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.